Abcellera Biologics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $5,050 | $6,507 | $7,323 | $9,954 |
Gross Profit | 5,050 | -31,788 | -30,714 | 3,188 |
EBITDA | -55,311 | -51,877 | -56,932 | -48,128 |
EBIT | -69,211 | -90,172 | -94,969 | -54,894 |
Net Income | -34,210 | -51,107 | -36,930 | -40,610 |
Net Change In Cash | 5,050 | 6,507 | 7,323 | 9,954 |
Free Cash Flow | -23,630 | -47,398 | -49,255 | -65,848 |
Cash | 156,325 | 126,640 | 173,312 | 148,572 |
Basic Shares | 294,327 | 294,851 | 294,217 | 292,723 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $28,833 | $38,025 | $485,424 | $11,611 |
Gross Profit | 28,833 | 38,025 | 418,988 | 11,611 |
EBITDA | -204,148 | -192,158 | 272,201 | -154 |
EBIT | -301,146 | -223,052 | 239,099 | -2,001 |
Net Income | -162,857 | -146,398 | 158,519 | -2,210 |
Net Change In Cash | 28,833 | 38,025 | 485,424 | 11,611 |
Cost of Revenue | -76,893 | -91,549 | ||
Free Cash Flow | -186,952 | -121,384 | 204,700 | 186,132 |
Cash | 156,325 | 133,320 | 386,535 | 476,142 |
Basic Shares | 294,327 | 289,166 | 314,827 | 318,294 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.12 |
2024-09-30 | -$0.17 |
2024-06-30 | -$0.13 |
2024-03-31 | -$0.14 |
